Homologous or heterologous administration of mRNA or adenovirus-vectored vaccines show comparable immunogenicity and effectiveness against the SARS-CoV-2 Omicron variant
Article in Expert Review of Vaccines (April 2024)
The most recent citing publications are shown below. View all 30 publications that cite this research output on Dimensions.
Article in Expert Review of Vaccines (April 2024)
Article in Tuberculosis (January 2023)
Article in Molecular Pharmaceutics (December 2022)